Related Experiment Video
Updated: Sep 14, 2026
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
A review of randomized trials comparing coronary angioplasty and bypass grafting
1Emory University, Department of Interventional Cardiology, Atlanta, GA 30322, USA.
Insights
Coronary atherosclerosis treatments like angioplasty and bypass surgery show similar survival rates. However, angioplasty requires more repeat procedures due to restenosis, impacting long-term costs.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Cardiac Surgery
Background:
- Coronary atherosclerosis is a leading cause of mortality, necessitating effective treatment strategies.
- Angioplasty and coronary artery bypass grafting (CABG) are established interventions for symptomatic disease.
- Direct comparative randomized trials are crucial for evaluating these treatment modalities.
Purpose of the Study:
- To directly compare the efficacy of angioplasty versus bypass surgery in patients with symptomatic coronary atherosclerosis.
- To assess long-term outcomes including mortality, myocardial infarction, and need for repeat revascularization.
- To evaluate the cost-effectiveness of both treatment strategies.
Main Methods:
- Randomized trials comparing angioplasty and bypass surgery in patients with multivessel coronary artery disease.
- Follow-up assessments included mortality, myocardial infarction rates, and repeat revascularization procedures.
- Economic analysis comparing initial and long-term costs of both interventions.
Main Results:
- Overall mortality and freedom from myocardial infarction were comparable between angioplasty and bypass surgery groups.
- Patients undergoing angioplasty experienced a significantly higher rate of repeat revascularization, primarily due to restenosis.
- This difference in repeat procedures was most pronounced in the first year post-intervention and decreased over time.
- Initial cost savings with angioplasty were offset by the costs associated with repeat interventions.
Conclusions:
- For patients with multivessel disease, both angioplasty and bypass surgery offer similar survival benefits.
- Restenosis remains a significant challenge for angioplasty, leading to increased repeat procedures and impacting long-term cost-effectiveness.
- Treatment choice should consider the trade-offs between procedural invasiveness, restenosis rates, and long-term economic implications.
Abstract:
Angioplasty and bypass surgery have become standard methods of treating patients with symptomatic coronary atherosclerosis. Although both procedures have been applied to a wide spectrum of patients with acceptable morbidity and mortality, only recently have randomized trials been performed to directly compare their efficacies. In patients with multivessel disease, overall mortality and freedom from myocardial infarction appear to be similar between the two treatment strategies. Primarily due to restenosis, the need for repeat revascularization procedures is significantly greater in patients who initially undergo angioplasty. Accordingly, this difference is most striking in the 1st year of follow-up and diminishes over time. The costs of the two treatment strategies reflect the restenosis problem as well. Although angioplasty initially costs less than bypass surgery, the cost savings largely abate after repeat interventions are performed.
More Related Videos
09:12Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
